Orange Book product · Brand (NDA)
JUXTAPID
LOMITAPIDE MESYLATE
At a glance
Apr 23, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 23, 2015
11 yr 4 mo ago
Today
Patent 7932268 expires
Listed method-of-use patent (U-1316) expiration.
Aug 19, 2027
in 1 yr 2 mo
Exclusivity ends · NPP
New patient population exclusivity (3 years)
Feb 25, 2029
in 2 yr 9 mo
Patent 12472172 expires
Listed method-of-use patent (U-4438) expiration.
Jul 29, 2041
in 15 yr 4 mo
Pharmaceutical detail
Active ingredient
LOMITAPIDE MESYLATE
Strength
EQ 30MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 203858
Product number
004
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (1)
- NPPNew patient population exclusivity (3 years)
Feb 25, 2029
in 2 yr 9 mo
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7932268 | Aug 19, 2027 | in 1 yr 2 mo | U-1316 |
| 12472172 | Jul 29, 2041 | in 15 yr 4 mo | U-4438 |
